These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29984351)

  • 1. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review.
    Kennedy-Martin T; Bae JP; Paczkowski R; Freeman E
    J Patient Rep Outcomes; 2017; 2():28. PubMed ID: 29984351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
    Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
    JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis.
    McSweeney L; Breckons M; Fattakhova G; Oluboyede Y; Vale L; Ternent L; Balp MM; Doward L; Brass CA; Beyer F; Sanyal A; Anstee QM
    JHEP Rep; 2020 Jun; 2(3):100099. PubMed ID: 32435754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.
    Grønkjær LL; Lauridsen MM
    JHEP Rep; 2021 Dec; 3(6):100370. PubMed ID: 34805816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
    O'Hara J; Finnegan A; Dhillon H; Ruiz-Casas L; Pedra G; Franks B; Morgan G; Hebditch V; Jönsson B; Mabhala M; Reic T; Van Thiel I; Ratziu V; Romero-Gomez M; Bugianesi E; Schattenberg JM; Anstee QM
    JHEP Rep; 2020 Oct; 2(5):100142. PubMed ID: 32775976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH).
    Chawla KS; Talwalkar JA; Keach JC; Malinchoc M; Lindor KD; Jorgensen R
    BMJ Open Gastroenterol; 2016; 3(1):e000069. PubMed ID: 27110379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Younossi ZM; Stepanova M; Younossi I; Racila A
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2093-2100.e3. PubMed ID: 30639779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in environmental enhancement and conservation activities for health and well-being in adults: a review of quantitative and qualitative evidence.
    Husk K; Lovell R; Cooper C; Stahl-Timmins W; Garside R
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010351. PubMed ID: 27207731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
    Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A
    Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Younossi ZM; Stepanova M; Lawitz EJ; Reddy KR; Wai-Sun Wong V; Mangia A; Muir AJ; Jacobson I; Djedjos CS; Gaggar A; Myers RP; Younossi I; Nader F; Racila A
    Am J Gastroenterol; 2019 Oct; 114(10):1636-1641. PubMed ID: 31464743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
    Younossi ZM; Stepanova M; Noureddin M; Kowdley KV; Strasser SI; Kohli A; Ruane P; Shiffman ML; Sheikh A; Gunn N; Caldwell SH; Huss RS; Myers RP; Wai-Sun Wong V; Alkhouri N; Goodman Z; Loomba R
    Hepatol Commun; 2021 Jul; 5(7):1201-1211. PubMed ID: 34278169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
    Witkowski M; Moreno SI; Fernandes J; Johansen P; Augusto M; Nair S
    Pharmacoeconomics; 2022 Aug; 40(8):751-776. PubMed ID: 35789987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient-reported quality of life.
    Heath L; Aveyard P; Tomlinson JW; Cobbold JF; Koutoukidis DA
    Hepatol Commun; 2022 Oct; 6(10):2623-2633. PubMed ID: 35903833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study.
    Doward LC; Balp MM; Twiss J; Slota C; Cryer D; Brass CA; Anstee QM; Sanyal AJ
    Patient; 2021 Sep; 14(5):533-543. PubMed ID: 33336323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements.
    Johansen P; Howard D; Bishop R; Moreno SI; Buchholtz K
    Pharmacoeconomics; 2020 May; 38(5):485-497. PubMed ID: 31919793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise interventions on health-related quality of life for people with cancer during active treatment.
    Mishra SI; Scherer RW; Snyder C; Geigle PM; Berlanstein DR; Topaloglu O
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008465. PubMed ID: 22895974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.